glp-1 parkinson's disease lancet The Emerging Role of RAs in Parkinson's disease - The Lancet

The role of tirzepatide, dual GIP and GLP-1 receptor agonist, in the management of type 2 diabetes: the SURPASS clinical trials

And for researchers concerned about psychological effects, the tirzepatide anxiety resource discusses similar GLP-1-related mechanisms that may apply to retatrutide as well

Phase 3 trials are still running, and Eli Lilly is expected to submit retatrutide for regulatory approval once the remaining trials report results across 2026

"There are some older-generation drugs that are safe and effective and are still in use," says Dr

Our goal is not only to help you manage symptoms but to support your long-term wellness

Contact the prescribing clinician, who can evaluate the degree of abnormality, symptoms, previous results, other medications, and whether repeat testing or additional evaluation is needed